Cerner - Pharmacist Digest

STAT+: Oracle Health chair says Cerner isn’t competing with Epic

STAT

MARCH 6, 2024

Cerner may have ceded U.S. Epic and Cerner have long been in a head-to-head race for medical software contracts. The playing field changed in 2022 when Cerner merged with cloud titan Oracle , coinciding with a loss in its large health system customers in the U.S., according to health care technology research firm KLAS.

Cerner

Cerner Hospitals

Cerner Enviza aims to accelerate therapies and improve patient outcomes

pharmaphorum

OCTOBER 28, 2021

26, 2021 — Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, Cerner Enviza SM , that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. president and CEO, Cerner.

Cerner

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

APRIL 11, 2023

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. Together, Cerner Enviza and John Snow Labs have all the right expertise, data and technology to make it happen.”

Cerner

Cerner Hospitals

Oracle and Cerner: A Leap Forward in Safety

PharmExec

OCTOBER 17, 2022

Combining Cerner Enviza’s real-world datasets containing de-identified, person-centric, longitudinal records offers a vast resource for expanding the potential of safety signaling.

Cerner

Is Oracle about to buy electronic health record provider Cerner?

pharmaphorum

DECEMBER 20, 2021

In a year already marked by big-ticket deals in the digital health arena, there may be even more to come, as reports circulate of a $30 billion offer looming for electronic health record (EHR) specialist Cerner by Oracle. The post Is Oracle about to buy electronic health record provider Cerner? billion this year. .”

Cerner

Cerner Medical Records

Cerner and LRVHealth invest $6m in digital health firm Xealth

pharmaphorum

AUGUST 7, 2020

Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. Xealth and Cerner hope to make it easier and more convenient for patients and clinicians to accelerate health care in a more consumer-centric experience.”.

Cerner

STAT+: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing

STAT

SEPTEMBER 20, 2022

2 Oracle Cerner, taking away dozens of customers. The Wisconsin-based company’s contracts now account for nearly half the nation’s hospital beds, and in recent months it has jumped out to a commanding lead over No. Continue to STAT+ to read the full story…

Cerner

Cerner Hospitals

Oncology treatment decisions aren’t just based on clinical data

pharmaphorum

NOVEMBER 9, 2021

Join this Cerner Enviza webinar, held in partnership with pharmaphorum, for a 45-minute, evidence-backed discussion on the paradoxical question that is “How do I succeed in oncology?”. Michael Gaschler, PhD , Senior Consultant, Oncology, Cerner Enviza. Jeanette Hodgson, Global Head of Qualitative Strategy, Cerner Enviza.

Cerner

Real-world evidence and qualitative research: the ELICIT podcast

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. Jeanette Hodgson , global head of qualitative strategy at, Cerner Enviza. Yew Ying Jie , senior analyst, Cerner Enviza.

Cerner

Real-world evidence and qualitative research: the ELICIT podcast

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. Jeanette Hodgson , global head of qualitative strategy at, Cerner Enviza. Yew Ying Jie , senior analyst, Cerner Enviza.

Cerner

People on the Move: November 2021

Outsourcing Pharma

NOVEMBER 4, 2021

This monthâs announcements of programs, names, appointments, hires, and other happenings includes items from Emmes, Science 37, Cerner and other companies.

Cerner

Elligo, Cerner join to expand clinical trial reach in communities

Outsourcing Pharma

DECEMBER 15, 2020

The two firms will work together to broaden the technology, tools, and resources available to hospitals and practices in less-accessible communities.

Cerner

Cerner Hospitals

Elligo hits 100-million patient mark with network

Outsourcing Pharma

FEBRUARY 2, 2021

Thanks to collaborations with Cerner, amassing of proprietary data and other achievements, the trial solutions firm has hit a significant access milestone.

Cerner

Connecting EHR to clinical trials: How to embrace the promise of real-world data

pharmaphorum

AUGUST 3, 2022

The key, according to Ryan Mogg, senior director of real-world data and clinical research at Cerner; Michael Ibara, chief data officer at Elligo; and Andy Stankus, general manager of real-world evidence at Kantar Health, was collecting and connecting the right data, and supporting sites to get involved.

Cerner

IBM sells off large parts of Watson Health business

pharmaphorum

JANUARY 24, 2022

Last month, arch-rival Oracle announced a $28 billion takeover of electronic health record company Cerner , while 2021 also saw Microsoft’s $19.7 IBM’s step back from health comes as tech rivals are still piling into the sector.

Cerner

Digital health financing falls to two-year low in first half

pharmaphorum

JULY 12, 2022

There are some warning signals in the numbers, including most notably an absence of digital health companies going public – zero in the first six months of the year, coming after 23 over the course of 2021 – while a few formerly public firms, including Castlight Health, SOC Telemed, and Cerner went back into private hands.

Cerner

Immunotherapies are the scientific answer to cancer, how important is marketing?

pharmaphorum

JANUARY 19, 2022

Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade. Yet how many other therapy areas have market leaders that don’t even have clinical approval in that indication?

Cerner

Pharmacist Digest

STAT+: Oracle Health chair says Cerner isn’t competing with Epic

Cerner Enviza aims to accelerate therapies and improve patient outcomes

Trending Sources

Cerner Enviza and FDA partner to develop AI drug safety tools

Oracle and Cerner: A Leap Forward in Safety

Is Oracle about to buy electronic health record provider Cerner?

Cerner and LRVHealth invest $6m in digital health firm Xealth

STAT+: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing

Oncology treatment decisions aren’t just based on clinical data

Real-world evidence and qualitative research: the ELICIT podcast

Real-world evidence and qualitative research: the ELICIT podcast

People on the Move: November 2021

Elligo, Cerner join to expand clinical trial reach in communities

Elligo hits 100-million patient mark with network

Connecting EHR to clinical trials: How to embrace the promise of real-world data

IBM sells off large parts of Watson Health business

Digital health financing falls to two-year low in first half

Immunotherapies are the scientific answer to cancer, how important is marketing?

Stay Connected